Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May;45(5):1079-1083.
doi: 10.1007/s40618-021-01725-y. Epub 2022 Jan 16.

Silent thyroiditis following vaccination against COVID-19: report of two cases

Affiliations
Case Reports

Silent thyroiditis following vaccination against COVID-19: report of two cases

M Capezzone et al. J Endocrinol Invest. 2022 May.

Abstract

Purpose: It is well established that thyroiditis and other thyroid disorders can be induced by COVID-19 infection, but there is limited information about the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We report two cases of thyrotoxicosis following SARS-CoV-2 vaccine.

Methods and results: Two young health care peoples (wife and husband) received a first dose of SARS-CoV-2 vaccine, and few weeks later developed clinical manifestations of thyroid hyperactivity, with increased thyroid hormone levels on thyroid function tests, suppressed thyroid-stimulating hormone and negative antithyroid antibodies, despite being healthy before vaccination. They were diagnosed at the 4th week after first dose of SARS-Cov-2 vaccine as silent thyroiditis and followed without treatment, since their symptoms were not severe. At the 6th week, the patients became wholly asymptomatic and their thyroid function returned to normal.

Conclusions: Thyrotoxicosis can occur after SARS-CoV-2 vaccination probably related to silent thyroiditis.

Keywords: Adverse vaccine reactions; COVID vaccine; Silent thyroiditis; Thyrotoxicosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to report. Maria Grazia Castagna is a member of Editorial Board.

Figures

Fig. 1
Fig. 1
HYPERLINK "sps:id::fig1||locator::gr1||MediaObject::0" a, b Thyroid ultrasound images of case 1 performed during the thyrotoxic phase. c, d Thyroid ultrasound images of case 2 performed during the thyrotoxic phase

References

    1. Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, Law CY, Leung EKH, To KKW, Tan KCB, Woo YC, Lam CW, Hung IFN, Lam KSL. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021;106:e926–e935. doi: 10.1210/clinem/dgaa813. - DOI - PMC - PubMed
    1. Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Investig. 2020;43(8):1171–1172. doi: 10.1007/s40618-020-01312-7. - DOI - PMC - PubMed
    1. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Investig. 2020;43:1027–1031. doi: 10.1007/s40618-020-01276-8. - DOI - PMC - PubMed
    1. İremli BG, Şendur SN, Ünlütürk U. Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. J Clin Endocrinol Metab. 2021;106:2600–2605. doi: 10.1210/clinem/dgab373. - DOI - PMC - PubMed
    1. Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sánchez Valadez TI, Jara LJ. Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid. 2021;31:1436–1439. doi: 10.1089/thy.2021.0142. - DOI - PubMed

Publication types

Substances